1. Medtech Insight
  2. >>Policy & Regulation

CMS Directors Urge Industry To Weigh In On MCIT Innovative Tech Proposal

Rule would supply direct reimbursement pathway for FDA breakthrough devices

 
• By Sue Darcey

Medicare agency reimbursement experts asked device technology firms to explain regulatory hurdles to getting proper reimbursements for their products in comments on an innovative technology rule.

Medicare, Health Concept

Sponsors of remote monitoring and telehealth devices have a golden opportunity to impact the way the US Centers for Medicare and Medicaid Services sets coding and reimbursements for Food and Drug Administration-approved breakthrough tech devices, CMS officials say.

A proposed rule on reimbursement of FDA breakthrough devices, Medicare Coverage of Innovative Technology, or MCIT, was published in late...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Medtech Insight

Execs On The Move: June 16–20, 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Dxcover Launches US Operations With New Headquarters In Tennessee

 
• By Natasha Barrow

Dxcover sets up new Clinical Laboratory Improvement Amendments (CLIA) lab in Franklin, Tennessee.

EnsoData Boosts AI Sleep Tech With $20M Series B Funding, Targets Underdiagnosis Crisis

 
• By Shubham Singh

EnsoData positions itself as device-agnostic and interoperable, with FDA-cleared software that can integrate with all major devices. CEO Mortara said this flexibility helps maximize patient reach by enabling both direct provider engagement and integration with device manufacturers.